AP treatment was sufficient to induce partial recovery of obesity-related stem cell depletion (Figures 7C and 7E) and to replenish CD133+ and Nestin+ cell abundance (Figures 7F and 7G). The gene discussed is PROM1; the disease is obesity due to melanocortin 4 receptor deficiency.